![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.025 | -1.47% | 1.675 | 1.65 | 1.70 | 1.725 | 1.675 | 1.70 | 13,052,849 | 12:32:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -1.76 | 9.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/2/2021 08:30 | Plenty of news to come these coking days and weeks! | ![]() losses | |
01/2/2021 08:29 | Sounds like it will be.. | ![]() losses | |
31/1/2021 23:58 | Link posted on LSE site by GGGT Public Health England (PHE) has awarded a contract to Beckman Coulter UK Ltd for the provision of Biomek i7 Hybrid MC+Span-8. Could it be the piece of kit for our test? The specified contract start date is 26 Feb 2021. | ![]() aquilla | |
31/1/2021 20:56 | Tip of the iceberg ... seriously .. millions are in the offing.Just hold ! | ![]() amaretto1 | |
31/1/2021 19:34 | Great find looks like the correct machines. Genedrive to supply the tests. Good luck all | ![]() seball | |
31/1/2021 19:12 | Courtesy of GGGT from LSE.Bid stats Order for I7 for uk which uses GDR test.https://bidstat | ![]() maxplus2 | |
31/1/2021 18:41 | Friday after hour sale was at 59p expect big drop tomorrow | ![]() justtrying1 | |
31/1/2021 18:31 | Great comparisons if you scroll down but if you need to be spoon fed ....well! | ![]() hazl | |
31/1/2021 16:29 | U don't have to ramp this .. esp this week ....GDR are in the big mix !! | ![]() amaretto1 | |
31/1/2021 15:45 | hazl- So what - No more data than available on ADVFN. | ![]() pugugly | |
31/1/2021 15:28 | Massive ramping going on.Looks like someone got spiked haha | ![]() ammu12 | |
31/1/2021 15:19 | Big sale - 16:35 - Friday = Late mark - 1,550,000 at 59.5307/ BIG QUERY _ Overhang cleared or more to come? | ![]() pugugly | |
31/1/2021 15:18 | Big sale - 16:35 - Friday = Late mark - 1,550,000 at 59.5307/ BIG QUERY _ Overhang cleared or more to come? | ![]() pugugly | |
31/1/2021 15:12 | https://twitter.com/ | ![]() jock3636 | |
31/1/2021 11:50 | You have missed the 55p twice already... more new coming in the coming weeks. | ![]() losses | |
30/1/2021 21:12 | I read somewhere once that if you feel you have picked a good company then pennies won't matter. | ![]() hazl | |
30/1/2021 21:10 | It's great that you're interested in this company. | ![]() hazl | |
30/1/2021 20:20 | Looking to buy more at 55p.lets see | ![]() letmepass | |
30/1/2021 19:15 | Thanks to Simon. 'SKY News - 30/1/21: Dr Clare Wenham, assistant professor of global health policy at London School of Economics, said the Covid-19 pandemic will not be over until the world’s population is protected. At the moment, the data is showing it’s going to be 2023-24 before the global vaccines are distributed to everybody,” she said.' | ![]() hazl | |
30/1/2021 19:12 | I think the gap is going to be filled first before any rise and seller offloading to do it | ![]() letmepass | |
30/1/2021 19:02 | 'As well as its progress on Covid-19 testing, Genedrive has also been buoyed by news that its HCV ID kit for diagnosing hepatitis C infection in low and middle-income countries has World Health Organisation (WHO) pre-qualified status. It is the first portable point-of-need device to be included on this list. CEO David Budd yesterday called it an “important milestone” in the evolution of the company, which until July 2016 was known as Epistem Holdings. It has been on the AIM market since 2007.' | ![]() hazl | |
30/1/2021 18:57 | 'We will enter 2021 with a stronger product portfolio and a stronger balance sheet and ready to enter a new growth phase for the Company and its assays." David Budd. | ![]() hazl | |
30/1/2021 18:53 | This was back in September.Quite interesting because though a positive piece, the share has dropped back since. Whilst the chart might not look brilliant,things can change and now we have had this news, and as soon as February, things will proceed,we have quite a bit to look forward to. IMO | ![]() hazl |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions